Director, Clinical Supply Chain

Olema Oncology is a clinical-stage biopharmaceutical company committed to transforming the standard of care and improving outcomes for patients living with breast cancer and beyond. It’s an exciting time to be part of Team Olema , with our transfor mation into a fully integrated oncology company well underway , t op-line data from our lead program expected later this year , and our first potential commercial launch on the horizon. Our leadproduct candidate,palazestrant, isa novel, orallyavailablecomplete estrogen receptor antagonist (CERAN)and selective estrogen receptor degrader (SERD)currently intwopivotalPhase 3clinicaltrials.We expect top-line data from OPERA-01,ourongoingPhase 3 trial ofpalazestrantas a monotherapy in patients withsecond- or third-lineER+/HER2-metastatic breast cancer (MBC), in the fallwhich, if successful, could lead to our first potentialapproval andcommercial launchin 2027. OPERA-02,ourPhase 3 trial ofpalazestrantin combination withribociblibin patients with frontlineER+/HER2- MBC, isenrolling patients.Togetherwith itsmechanism of action, pharmacokinetic properties,andthe potential todemonstrateactivity in bothESR1wild-type and mutant tumors,palazestranthas the potential totransform the metastatic breast cancer treatment paradigm andaccessa$15 billionglobal market opportunity. Our follow-on product candidate, OP-3136, is a potent KAT6 inhibitor withthepotential to generate further value and meaningfullyimpactthemetastatic breastcancertreatment landscape – particularly in combination withpalazestrant.We recently reportedencouragingPhase 1monotherapydata from this programacross multiple solid tumor types andareadvancingpatientenrollment in theongoingcombinationarmsin MBC. Aspiring to transform the metastatic treatment paradigm an ambitious endeavor that requires aresolute approach todeveloping better therapies and apassionateteamdedicated tohelping the patients we serve feelbetter,longer.Wepossessadeepcommitment toour shared purpose,thesustained pursuit of excellence, cultivatingthecouragerequiredto advance our programs, drive to succeed, and a collective capacity for adaptability through learning, growth, and evolution. Team Olema is made up of nimble self-starters who bring consistency in their quest for the extraordinary every single day. Ifyou’rereadyto bepart of atenacious,courageous,agile, andgrowingteam,join us in makinga profound impact,together– for our patients, for your career, and for what’s beyond . About the Role >>> Director, Clinical Supply Chain As a Director, Clinical Supply Chain reporting to the Vice President Clinical Supply Chain, you will have oversight of all aspects of the clinical supply chain to ensure uninterrupted and timely clinical drug supply for one of Olema’s largest, late phase clinical programs. This highly cross-functional role will partner closely with Clinical Operations, CMC/Technical Operations, Quality, Regulatory, and external vendors to support study execution and ensure clinical supply readiness as programs advance toward registration and commercialization. This hands-on role requires an independent self-starter with extensive experience in end-to-end clinical supply chain management. The role will be based out of either our San Francisco or our Cambridge office and require occasional travel . Your work will primarily encompass: Lead end-to-end clinical supply chain strategy and execution for a global, late-stage clinical program Provide technical, functional, and program leadership across clinical supply planning and execution, including alignment with manufacturing and release schedules and direct oversight of CDMOs and other external partners Develop and implement global Clinical Supply Chain strategies and deliver clinical supplies for all phases of clinical development Develop and maintain demand forecasts and executable supply plans based on enrollment assumptions, country and site activation timelines, dosing requirements, manufacturing schedules, and evolving study scenarios Manage global inventory and distribution strategies, including depot management, import/export and customs requirements, storage and handling, and oversight of third-party manufacturers and logistics providers Lead scenario planning and contingency strategies addressing enrollment variability, manufacturing delays, comparator availability, expiry and shelf-life constraints, and potential distribution disruptions Oversee packaging, labeling, distribution, depot strategy, product accountability, returns, reconciliation, destruction, and clinical supply study-closeout activities Lead IRT/RTSM supply strategy, design, setup, testing/UAT, implementation, change control, and ongoing performance, including inventory and resupply requirements Represent Clinical Supply Chain on cross-functional study and program teams, providing strategic guidance on supply assumptions, risks, timelines, and decisions Work collaboratively with CMC, Clinical Operation, Quality Assurance, Regulatory, Finance and Legal Partner with Quality on deviations, investigations, root-cause analyses, CAPAs, vendor qualifications, and clinical supply–related procedures Proactively identify, assess, and mitigate clinical supply risks; develop contingency plans and drive timely cross-functional decisions and escalation when program milestones or patient supply may be affected Lead clinical supply readiness activities supporting NDA submissions, regulatory approval, and transition toward commercial supply , as applicable Ensure clinical supply activities and documentation remain compliant and inspection-ready in accordance with applicable GMP, GCP, GDP, regulatory, quality, and company requirements Develop and manage clinical supply budgets, forecasts, and vendor spend while balancing supply assurance, inventory exposure, timelines, and cost Stay current with state-of-the art approaches and applicable global regulations and industry standards Ideal Candidate Profile >>> Late Phase Clinical Supply Knowledge A love of challenging, important work. We are a pragmatic team, driven to imagine and develop meaningful therapies for improving lives. All employees within our company play a unique and crucial role in our success, both in accomplishing our mission and building a positive company culture. As such, we are looking for someone with the right combination of knowledge, experience, and attributes for this role. Knowledge Bachelor's degree in a scientific, engineering, supply chain, operations, or related discipline required; advanced degree preferred Late phase clinical development and global clinical supply chain management experience is required Deep understanding of end-to-end clinical supply chain management and global clinical trial execution Strong knowledge of GMP requirements and applicable global regulations governing clinical supplies Strong understanding of clinical development, including late-stage and registrational studies Knowledge of clinical supply systems and processes, including IRT/RTSM, QMS, inventory management, forecasting, and planning tools Experience: Minimum of 15+ years of biotechnology/pharmaceutical industry experience, with 8+ years in clinical supply chain management. (Oncology clinical trial experience strongly preferred) Demonstrated experience leading end-to-end clinical supply strategy for global, complex clinical programs Experience managing comparator and/or standard-of-care drug supply Experience supporting clinical programs approaching NDA/marketing applications and commercial readiness is strongly preferred Extensive experience managing forecast demands and inventories Strong experience in clinical label development, global shipping, and customs Excellent project management skills 5+ years of people management experience Demonstrated successful partnerships with the Clinical Operations team to deliver in the late phase of drug development Attributes: Strategic thinker with the ability to remain hands-on and execute in a growing organization Strong leadership, influencing, and decision-making skills Excellent project management, planning, and organizational capabilities Proactive approach to identifying risks and developing solutions before impacting clinical programs Strong communication and cross-functional collaboration skills Comfortable operating with ambiguity and adapting quickly as program priorities evolve High degree of ownership, accountability, and attention to detail Ability to balance speed, quality, cost, and risk while maintaining a strong focus on patients and clinical program needs The base pay range for this position is expected to be $205,000 -$235,000 annually, however the base pay offered may vary depending on location, market, job related knowledge, #J-18808-Ljbffr Olema Oncology